PTIX: Protagenic Therapeutics Company Short-Term Debt
This daily price chart on the GURU.Markets platform illustrates the price action of Protagenic Therapeutics (PTIX), where the specific short-term debt metric equals 0.00. High research expenditures and exclusive rights to PT00114 peptides create significant barriers to entry for competitors under strict FDA oversight. Stable management ensures prudent capital allocation while executing the plan to develop non-addictive treatments for anxiety and depression.
Analytical breakdowns and data insights for company Protagenic Therapeutics Inc. (PTIX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Protagenic Therapeutics|PTIX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Protagenic|PTIX - Company Cumulative Indebtedness|Debts to Book Capitalization Protagenic Therapeutics, Inc.|PTIX - Company Long-Term Debts|Company Short-Term Debts Protagenic Therapeutics|Quick Ratio protagenic.com
- earnings and multiples data:
Summary company analytics:protagenic.com (PTIX)
To identify the sector's fundamental leaders, the analyst evaluates liquidity through the aggregate of liabilities maturing within one year, determining the business's ability to service current loans without compromising operational stability. Given the secure US jurisdiction and the humanitarian status of Protagenic Therapeutics (PTIX) developments, fluctuations in short-term debt reflect the real cost of borrowed capital, allowing investors to promptly detect the risk of asset overheating.
Competitors of Protagenic Therapeutics (PTIX)
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|xenon-pharma.com - Current Liabilities|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|SUPN (Supernus Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Denali Corp (DNLI) - Short-Term Debt|HRMY: Company Current Liabilities|biohavenpharma.com - Amount of Current Liabilities|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|PRAX (Praxis Medicines) - Company Short-Term Debts|AVXL - Short-Term Indebtedness|Company Short-Term Debts CBLL|PRTA - Short-Term Debt|Company Short-Term Debt Alector ALEC|ANNX: Company Short-Term Indebtedness|Omeros Corp. - Company Short-Term Debts|Short-Term Debt Volume Neurogene Therapeutics NGNE|ACIU: Company Short-Term Debts|Company Current Liabilities voyagertherapeutics.com|Company Current Liabilities NMRA|SCLX: Company Short-Term Loans and Borrowings|Company Current Liabilities TVGN (Tevogen Bio Holdings, Inc.)|Amount of Current Liabilities ACOG|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|Short-Term Debt Assertio Holdings, Inc.|coyatherapeutics.com (COYA) - Company Short-Term Debt|Vistagen - Company Short-Term Loans and Borrowings|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debts acumenpharm.com|Company Short-Term Debt CervoMed (CRVO)|ATHE: Current Liabilities|Company Short-Term Debts CLNN (Clene)|PepGen Inc (PEPG) - Short-Term Debt|JUNS: Company Current Liabilities|RLMD - Company Short-Term Debts|ANVS (Annovis Bio) - Company Current Liabilities|GRCE: Amount of Current Liabilities|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|ANEW Medical, Inc. (KLTO) - Short-Term Debt Volume|Company Short-Term Debts NRSN|Company Current Liabilities revivapharma.com RVPH|Company Short-Term Debt MetaVia MTVA|Short-Term Debt Volume NeurAxis Inc. (NRXS)|HSDT - Company Short-Term Debt|Current Liabilities PASG|NEUP (bionomics.com.au) - Company Current Liabilities|NERV: Amount of Current Liabilities|ATHA (Athira Pharma) - Company Short-Term Debts|Addex Therapeutics Ltd. (ADXN) - Short-Term Debt Volume|Company Current Liabilities ALZN (Alzamend Neuro, Inc.)|cyclerion.com - Company Short-Term Indebtedness|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|CRGT: Company Short-Term Indebtedness|Avenue Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Brainstorm Cell Therapeutics Inc.|CARA (Cara Therapeutics, Inc) - Company Current Liabilities|Chromocell (CHRO) - Company Short-Term Debts|Company Short-Term Debt Eliem Therapeutics, Inc.|ITCI: Company Short-Term Loans and Borrowings|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|MRNS - Short-Term Debt|Company Short-Term Debt NKGen NKGN|NRBO (NeuroBo Pharma) - Current Liabilities|SAGE - Company Short-Term Debt|Company Short-Term Loans and Borrowings SNPX (synaptogen.com)|Trevena (TRVN) - Company Short-Term Debt|Short-Term Debt Vigil Neuroscience, Inc. (VIGL)|Company Current Liabilities WENA|CERE (Cerevel Corp) - Amount of Current Liabilities